<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T15:30:28.019689",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "GlaLSTM",
    "Glaucoma Detection",
    "Biomarker Analysis",
    "Neural Network"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "GlaLSTM": 0.8,
    "Glaucoma Detection": 0.82,
    "Biomarker Analysis": 0.78,
    "Neural Network": 0.75
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "GlaLSTM",
        "canonical": "GlaLSTM",
        "aliases": [
          "Concurrent LSTM Stream Framework"
        ],
        "category": "unique_technical",
        "rationale": "GlaLSTM is a novel framework specifically designed for glaucoma detection, offering unique insights into biomarker analysis.",
        "novelty_score": 0.85,
        "connectivity_score": 0.65,
        "specificity_score": 0.9,
        "link_intent_score": 0.8
      },
      {
        "surface": "glaucoma detection",
        "canonical": "Glaucoma Detection",
        "aliases": [
          "glaucoma diagnosis"
        ],
        "category": "specific_connectable",
        "rationale": "Glaucoma detection is a critical application area that connects to various medical imaging and diagnostic techniques.",
        "novelty_score": 0.5,
        "connectivity_score": 0.85,
        "specificity_score": 0.78,
        "link_intent_score": 0.82
      },
      {
        "surface": "biomarker mining",
        "canonical": "Biomarker Analysis",
        "aliases": [
          "biomarker discovery"
        ],
        "category": "specific_connectable",
        "rationale": "Biomarker analysis is essential for understanding disease mechanisms and can link to broader biomedical research.",
        "novelty_score": 0.6,
        "connectivity_score": 0.8,
        "specificity_score": 0.75,
        "link_intent_score": 0.78
      },
      {
        "surface": "LSTM",
        "canonical": "Neural Network",
        "aliases": [
          "Long Short-Term Memory"
        ],
        "category": "broad_technical",
        "rationale": "LSTM is a type of neural network architecture that is widely used in time-series analysis and can connect to various deep learning applications.",
        "novelty_score": 0.45,
        "connectivity_score": 0.9,
        "specificity_score": 0.7,
        "link_intent_score": 0.75
      }
    ],
    "ban_list_suggestions": [
      "method",
      "experiment",
      "performance"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "GlaLSTM",
      "resolved_canonical": "GlaLSTM",
      "decision": "linked",
      "scores": {
        "novelty": 0.85,
        "connectivity": 0.65,
        "specificity": 0.9,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "glaucoma detection",
      "resolved_canonical": "Glaucoma Detection",
      "decision": "linked",
      "scores": {
        "novelty": 0.5,
        "connectivity": 0.85,
        "specificity": 0.78,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "biomarker mining",
      "resolved_canonical": "Biomarker Analysis",
      "decision": "linked",
      "scores": {
        "novelty": 0.6,
        "connectivity": 0.8,
        "specificity": 0.75,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "LSTM",
      "resolved_canonical": "Neural Network",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.9,
        "specificity": 0.7,
        "link_intent": 0.75
      }
    }
  ]
}
-->

# GlaLSTM: A Concurrent LSTM Stream Framework for Glaucoma Detection via Biomarker Mining

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.LG|cs.LG]]
**PDF**: [Download](https://arxiv.org/pdf/2408.15555.pdf)
**Category**: cs.LG
**Published**: 2025-09-24
**ArXiv ID**: [2408.15555](https://arxiv.org/abs/2408.15555)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/X-GAN_ A Generative AI-Powered Unsupervised Model for Main Vessel Segmentation of Glaucoma Screening_20250923|X-GAN: A Generative AI-Powered Unsupervised Model for Main Vessel Segmentation of Glaucoma Screening]] (82.8% similar)
- [[2025-09-23/Explainable Gait Abnormality Detection Using Dual-Dataset CNN-LSTM Models_20250923|Explainable Gait Abnormality Detection Using Dual-Dataset CNN-LSTM Models]] (81.8% similar)
- [[2025-09-23/Thermal Imaging-based Real-time Fall Detection using Motion Flow and Attention-enhanced Convolutional Recurrent Architecture_20250923|Thermal Imaging-based Real-time Fall Detection using Motion Flow and Attention-enhanced Convolutional Recurrent Architecture]] (81.4% similar)
- [[2025-09-22/EvoBrain_ Dynamic Multi-channel EEG Graph Modeling for Time-evolving Brain Network_20250922|EvoBrain: Dynamic Multi-channel EEG Graph Modeling for Time-evolving Brain Network]] (81.0% similar)
- [[2025-09-24/GluMind_ Multimodal Parallel Attention and Knowledge Retention for Robust Cross-Population Blood Glucose Forecasting_20250924|GluMind: Multimodal Parallel Attention and Knowledge Retention for Robust Cross-Population Blood Glucose Forecasting]] (81.0% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Neural Network|Neural Network]]
**ğŸ”— Specific Connectable**: [[keywords/Glaucoma Detection|Glaucoma Detection]], [[keywords/Biomarker Analysis|Biomarker Analysis]]
**âš¡ Unique Technical**: [[keywords/GlaLSTM|GlaLSTM]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2408.15555v3 Announce Type: replace-cross 
Abstract: Glaucoma is a complex group of eye diseases marked by optic nerve damage, commonly linked to elevated intraocular pressure and biomarkers like retinal nerve fiber layer thickness. Understanding how these biomarkers interact is crucial for unraveling glaucoma's underlying mechanisms. In this paper, we propose GlaLSTM, a novel concurrent LSTM stream framework for glaucoma detection, leveraging latent biomarker relationships. Unlike traditional CNN-based models that primarily detect glaucoma from images, GlaLSTM provides deeper interpretability, revealing the key contributing factors and enhancing model transparency. This approach not only improves detection accuracy but also empowers clinicians with actionable insights, facilitating more informed decision-making. Experimental evaluations confirm that GlaLSTM surpasses existing state-of-the-art methods, demonstrating its potential for both advanced biomarker analysis and reliable glaucoma detection.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì—ì„œëŠ” ë…¹ë‚´ì¥ ì§„ë‹¨ì„ ìœ„í•´ ìƒˆë¡œìš´ LSTM ê¸°ë°˜ì˜ GlaLSTM í”„ë ˆì„ì›Œí¬ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. ì´ ëª¨ë¸ì€ ê¸°ì¡´ì˜ CNN ê¸°ë°˜ ëª¨ë¸ê³¼ ë‹¬ë¦¬ ì ì¬ì ì¸ ë°”ì´ì˜¤ë§ˆì»¤ ê°„ì˜ ê´€ê³„ë¥¼ í™œìš©í•˜ì—¬ ë…¹ë‚´ì¥ì„ íƒì§€í•˜ë©°, ëª¨ë¸ì˜ í•´ì„ ê°€ëŠ¥ì„±ì„ ë†’ì—¬ ì£¼ìš” ê¸°ì—¬ ìš”ì¸ì„ íŒŒì•…í•  ìˆ˜ ìˆê²Œ í•©ë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, GlaLSTMì€ ê¸°ì¡´ ìµœì²¨ë‹¨ ë°©ë²•ë“¤ë³´ë‹¤ ë†’ì€ ì •í™•ë„ë¥¼ ë³´ì´ë©°, ì„ìƒì˜ì—ê²Œ ìœ ìš©í•œ í†µì°°ì„ ì œê³µí•˜ì—¬ ë” ë‚˜ì€ ì˜ì‚¬ ê²°ì •ì„ ì§€ì›í•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ë…¹ë‚´ì¥ì€ ì‹œì‹ ê²½ ì†ìƒì„ íŠ¹ì§•ìœ¼ë¡œ í•˜ëŠ” ë³µì¡í•œ ì•ˆêµ¬ ì§ˆí™˜ìœ¼ë¡œ, ì•ˆêµ¬ ë‚´ì•• ìƒìŠ¹ ë° ë§ë§‰ ì‹ ê²½ ì„¬ìœ ì¸µ ë‘ê»˜ì™€ ê°™ì€ ë°”ì´ì˜¤ë§ˆì»¤ì™€ ê´€ë ¨ì´ ìˆìŠµë‹ˆë‹¤.
- 2. GlaLSTMì€ ì ì¬ì  ë°”ì´ì˜¤ë§ˆì»¤ ê´€ê³„ë¥¼ í™œìš©í•˜ì—¬ ë…¹ë‚´ì¥ì„ íƒì§€í•˜ëŠ” ìƒˆë¡œìš´ LSTM ìŠ¤íŠ¸ë¦¼ í”„ë ˆì„ì›Œí¬ë¡œ, ê¸°ì¡´ì˜ CNN ê¸°ë°˜ ëª¨ë¸ë³´ë‹¤ ë” ê¹Šì€ í•´ì„ ê°€ëŠ¥ì„±ì„ ì œê³µí•©ë‹ˆë‹¤.
- 3. GlaLSTMì€ ì£¼ìš” ê¸°ì—¬ ìš”ì¸ì„ ë°í˜€ë‚´ê³  ëª¨ë¸ì˜ íˆ¬ëª…ì„±ì„ ë†’ì—¬, ì„ìƒì˜ì—ê²Œ ì‹¤í–‰ ê°€ëŠ¥í•œ í†µì°°ë ¥ì„ ì œê³µí•¨ìœ¼ë¡œì¨ ë” ë‚˜ì€ ì˜ì‚¬ ê²°ì •ì„ ë•ìŠµë‹ˆë‹¤.
- 4. ì‹¤í—˜ í‰ê°€ ê²°ê³¼, GlaLSTMì€ ê¸°ì¡´ ìµœì²¨ë‹¨ ë°©ë²•ì„ ëŠ¥ê°€í•˜ì—¬ ê³ ê¸‰ ë°”ì´ì˜¤ë§ˆì»¤ ë¶„ì„ê³¼ ì‹ ë¢°í•  ìˆ˜ ìˆëŠ” ë…¹ë‚´ì¥ íƒì§€ì— ì ì¬ë ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.


---

*Generated on 2025-09-24 15:30:28*